QuidelOrtho
Sarang Amin, CFA, currently serves as Senior Manager of Corporate Development at QuidelOrtho since April 2022, where responsibilities include leading corporate development initiatives, growth equity investments, and M&A strategies for a global diagnostics leader. Previously, Sarang held significant roles at Ortho Clinical Diagnostics, contributing to major transactions such as an $8B merger with Quidel and a $1.4B IPO due diligence effort, alongside strategic finance activities. Earlier experience includes strategic corporate finance at Vantage Specialty Ingredients, Inc., and early career positions focused on investment and strategy while pursuing an MBA and CFA certification. Sarang holds an MBA from The University of Western Australia and a Bachelor's Degree in Chemistry from Thomas Jefferson University.
This person is not in any teams
This person is not in any offices
QuidelOrtho
15 followers
At QuidelOrtho, we’re changing lives one test at a time. With precision and passion, we give people the clarity to create better health outcomes. Our focus is providing the intelligence people need in the moments they need them most. To get there, we imagine, invent, push and pursue for more accurate and reliable diagnostics, faster. Since day one, we’ve provided breakthrough solutions to healthcare professionals. Now, we’re creating a clearer picture of health for more people globally. From home to hospital, lab to clinic, we’re helping people everywhere move forward – going the extra mile for everyone we serve. Together, we're advancing diagnostics to power a healthier future.